U.S., Lilly strike deal for potential COVID-19 drug
The U.S. government will pay as much as $1.19 billion to Eli Lilly to secure nearly 1 million doses of its experimental COVID-19 antibody treatment.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook